MedPath

ENDOmetriosis Robotic Assisted Surgery

Not Applicable
Recruiting
Conditions
Endometriosis
Registration Number
NCT06445179
Lead Sponsor
GCS Ramsay Santé pour l'Enseignement et la Recherche
Brief Summary

The purpose of this study is to compare the robot-assisted approach with the laparoscopic approach in terms of reducing the rates of intraoperative and postoperative complications in patients undergoing total hysterectomy for DIE and adenomyosis without digestive tract involvement.

Detailed Description

The ENDO-RAS trial aims to evaluate the safety and effectiveness of robot-assisted laparoscopy compared to conventional laparoscopy for hysterectomy in patients with Deep infiltrating endometriosis and adenomyosis without digestive tract involvement, as verified by magnetic resonance imaging and classified using both the ENZIAN and Deep Pelvic Endometriosis Index classifications. These classifications are used to evaluate Deep infiltrating endometriosis and reproducibly predict the occurrence of postoperative complications.

Eligible patients will be recruited from the gynecological surgery department after meeting the inclusion and non-inclusion criteria and signed informed consent forms. Participants will then be randomly assigned to receive either robot-assisted total laparoscopic hysterectomy or total laparoscopic hysterectomy.

The ENDO-RAS Trial is a multicenter, randomized, controlled, and open-label study. Eligible patients will be randomized into two parallel groups.

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
224
Inclusion Criteria
  • ≥ 18 years of age.
  • Diagnosed adenomyosis, either internal or external (magnetic resonance imaging) per the Enzian and dPEI classifications.
  • Diagnosed deep infiltrating endometriosis per the Enzian and dPEI classifications, without the involvement of the digestive tract.
  • Failure of first- and second-line medical treatment.
  • Eligibility for total hysterectomy with complete removal of endometriosis lesions.
  • Participants covered by entitled to social security.
  • All participants must provide written informed consent before undergoing the surgical procedure.
Exclusion Criteria
  • Digestive tract involvement.
  • Adenomyosis only.
  • Contraindications to surgery.
  • Participants who are under guardianship, curatorship, or deprivation of liberty.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Intra and post-operative complication rates3 months

Rate of intra- and post-operative complications (Clavien-Dindo grade 2 or higher) following surgery (Total Laparoscopic Hysterectomy).

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

Hôpital Privé de Provence

🇫🇷

Aix-en-Provence, France

Hôpital Privé le Bois

🇫🇷

Lille, France

Hôpital Privé de Provence
🇫🇷Aix-en-Provence, France
Jean-Philippe ESTRADE, MD
Contact
jeanphilippeestrade@me.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.